Top Markets
#1 MON MON +2,759.42%
#2 $1 is all you need $1 is all you need +1,328.53%
#3 PYTHIA PYTHIA +44.53%
#4 eCash eCash +32.94%
#5 Siren Siren +24.14%
#6 Janction Janction +19.65%
#7 SAFEcoin SAFEcoin +17.31%
#8 PinGo PinGo +15.88%
#9 Velvet Velvet +15.84%
#10 Decred Decred +12.95%
Coin of the day
MON MON
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Rang in Aktien #13314
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Aktienkurs
$0.30780727
Marktkapitalisierung
$94.19M
Veränderung (1 Tag)
-0.19%
Veränderung (1 Jahr)
-34.73%
Land
FR
Handel Sensorion SA (ALSEN)

Kategorie

Healthcare
Kursverlauf für Sensorion SA (ALSEN)
Höchster Schlusskurs: $0.30 am 2026-07-01

Niedrigster Schlusskurs: $4.88 am 2015-04-01
Kursverlauf der Aktie von Sensorion SA von 2015 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -14.19%
2025 -35.43%
2024 42.20%
2023 21.00%
2022 -80.41%
2021 12.23%
2020 121.36%
2019 -30.56%
2018 -66.86%
2017 -29.31%
2016 -42.01%
2015 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $49.28 -28.51%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $482.59 2.93%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $663.74 16.91%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $281.36 41.09%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $869.87 55.27%
NL